Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.23.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities

These following common stock equivalents were excluded in the computation of the net loss per share because their effect is anti-dilutive:

  

  March 31, 2023 (Unaudited)       March 31, 2022 (Unaudited)    
Options to purchase common stock     3,467,915       302,500  
Warrants to purchase common stock     9,148,880       2,337,274  
Unvested restricted common stock     -       681,270  
Total anti-dilutive securities      12,616,795         3,321,044